Urokinase API

About BBT Biotech

BBT Biotech is a private, revenue-generating German CDMO and product company focused on biologics. It leverages integrated capabilities in upstream fermentation and downstream purification to manufacture a portfolio of APIs, including thrombolytic enzymes (streptokinase, urokinase) and probiotic/postbiotic strains. The company's value proposition is built on GMP-compliant manufacturing, in-house R&D and quality control, and serving clients from development through to commercial-scale production. Its established product sales and contract services position it in the growing market for biologics and live biotherapeutic products.

Therapeutic Areas

Other Thrombolysis Drugs